摘要 |
The present invention provides a compound having melanocortin receptor agonist activity or antagonist activity, which is a novel biaryl compound represented by the formula (I): wherein ring A and ring B are optionally further substituted 6-membered aromatic rings; X is -CONR<SUP>4</SUP>-, -SO<SUB>2</SUB>NR<SUP>4</SUP>-, -CH<SUB>2</SUB>NR<SUP>4</SUP>- (R<SUP>4 </SUP>is a hydrogen atom, an optionally substituted hydrocarbon group, etc.), etc.; Y is a spacer having 1 to 12 atoms, etc.; Z is -CONR<SUP>6</SUP>-, -CO- (R<SUP>6 </SUP>is a hydrogen atom, an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group), etc.; R<SUP>1 </SUP>is an optionally substituted amino group, etc.; R<SUP>2 </SUP>is an optionally substituted hydrocarbon group, etc.; R<SUP>3 </SUP>is an optionally substituted hydrocarbon group, etc.; and R<SUP>5 </SUP>is an optionally substituted hydrocarbon group, etc.; or a salt thereof.
|